Lanlan Chen

[eGastroenterology @eGastro_BMJ]

📢 New Editorial in #eGastroenterology

🔄 Dr Lanlan Chen, Prof. Frank Tacke and their team, from Charité – Universitätsmedizin Berlin, Germany, reframe #MASLD, #MetALD and #ALD as an evolving continuum rather than fixed diagnoses.

🧭 Tracking alcohol exposure, metabolic health and liver fibrosis over time—supported by tools such as PEth—could improve risk stratification and personalised care. #SteatoticLiverDisease #Hepatology

🔗 Explore the article: https://t.co/stqDPQs5x5

@LanlanChen10 @Tacke_lab @Gut_BMJ @BMJOpen_Gastro @BMJ_Open @FrontGastro_BMJ

[Lanlan Chen @LanlanChen10]

Prospects of Mendelian randomization in hepatology: a comprehensive literature review with practice guidance
https://t.co/jGmHOgaYrH

[Lanlan Chen @LanlanChen10]

Prospects of Mendelian Randomization in Hepatology: A Comprehensive Literature Review with Practice Guidance
https://t.co/IovjOUH2sw

[Lanlan Chen @LanlanChen10]

Reviewing the function of macrophages in liver disease: Expert Review of Gastroenterology & Hepatology: Vol 0, No 0 https://t.co/RLbYIhkYcr

[eGastroenterology @eGastro_BMJ]

🧬 New insights on hepatocellular carcinoma (HCC)!
📖 New review from Prof. Guillermo Mazzolini, Prof. Juan, and colleagues from Universidad Austral and other institutions provides an in-depth discussion of the critical role of epigenetic mechanisms in the development and progression of HCC, highlighting how DNA methylation, histone modifications, and metabolic dysregulation contribute to tumor growth, immune evasion, and therapeutic resistance. #Epigenetics #HCC
🔬Review: Epigenetic mechanisms involved in hepatocellular carcinoma development and progression
🔗Read more: https://t.co/wiZFh5HJew
@Gut_BMJ @FrontGastro_BMJ @BMJ_Open @BMJOpen_Gastro

[Stephen Burgess @stevesphd]

Our review "Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles" written together with @htcronje and published at @eGastro_BMJ is now available at https://t.co/b6i9wnJgBJ. Brief thread:

[eGastroenterology @eGastro_BMJ]

📣 Share our latest article! 📝 "Aetiology, Diagnosis, and Management for Ischaemic Cholecystitis: Current Perspectives" by Prof. Favela and his colleagues from the University of Wisconsin, USA. 🏥

https://t.co/ws9sFtp4w7

@Gut_BMJ @FrontGastro_BMJ @BMJOpen_Gastro

[eGastroenterology @eGastro_BMJ]

🌐 Delighted to present "New horizons of human genetics in digestive diseases" 🧬 by our Editor-in-Chief, Prof. Guoyue Lv! 📖 Gain fresh perspectives on the intersection of genetics and digestive health.

https://t.co/1LU563fjEY

@Gut_BMJ @BMJOpen_Gastro @FrontGastro_BMJ

[eGastroenterology @eGastro_BMJ]

🔍Check out our latest article, "Horizon scanning: new and future therapies in the management of inflammatory bowel disease," by Dr. Aditi Kumar and Prof. Philip J Smith from the UK. #IBD #Healthcare 📚🩺
https://t.co/PZT3O8CCED
@Gut_BMJ @FrontGastro_BMJ @BMJOpen_Gastro

[eGastroenterology @eGastro_BMJ]

🙌 A review paper by Prof. Mohammed Eslam & Prof. Jacob George from Westmead Hospital and University of Sydney.

'Two years on, a perspective on MAFLD' via

https://t.co/mKE8CwRcvh

@bmj_company @Gut_BMJ @BMJOpen_Gastro @FrontGastro_BMJ

[Frontiers - Pharmacology and Toxicology @FrontPharmacol]

New Research: Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization study https://t.co/qr3AOYCHt3 #pharmacology